--- title: Patient recruitment for clinical trials at Profil description: The Profil diabetes patient database is an extensive and carefully maintained resource for pharmaceutical and medical device trials. --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://www.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com?hsLang=en-us) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) # [![Recruitment header](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_FurtherServices.jpg?width=1077&height=260&name=Header_1077x260px_FurtherServices.jpg) Patient Recruitment Patient recruitment for clinical trials](https://www.profil.com/services/patient-recruitment#) ## Large patient database  As a clinical study center, Profil understands that a diabetes patient database must be extensive and kept up to date. Rapid enrollment or appropriate patients and healthy subjects is key to the successful and timely completion of clinical trials. To ensure in-time recruitment, Profil has developed a database of more than 26,000 patients with type 1 and type 2 diabetes and obese and lean healthy subjects. To meet specific trial requirements, this database can be filtered for major in- and exclusion criteria including but not limited to medical history, laboratory data and concomitant medication (both ingredients and substance classes as coded by the WHO Drug Dictionary). A dedicated in-house database team of three and ten recruitment coordinators remain in close contact with potential study subjects to ensure that the database is always up to date. ### Very low drop-out rates Honoring timelines is about more than just finding study subjects quickly. As the average drop-out rates of all clinical trials is about 30%, many studies are delayed unnecessarily. At Profil, we achieve extremely low average drop-out rates of 7.5% (among randomized subjects in the years 2014-2018), which helps us keep cost low, lets us create more reliable study timelines and ultimately get you the results you need faster. ### Facts and Figures - Database with > 26,000 active entries (as of November 2022) > 11,000 with type 2 diabetes > 5,700 with type 1 diabetes > 9,600 healthy subjects including defined as obese - Records include medical history, lab data, BMI and medication (acc. to WHO Drug Dictionary) - Ethnic groups: Caucasians, Japanese - Average drop-out rates of only 7.5% ![pikto2.png](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_NewWebinar.png?width=62&height=70&name=Icon_NewWebinar.png) ### Test our database Do you already have a study outline? Then test if we can recruit your study. [![Check Study](https://no-cache.hubspot.com/cta/default/481167/e30bdac0-92ef-4985-bb04-0c8a82eae82e.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/e30bdac0-92ef-4985-bb04-0c8a82eae82e) ![Dr. Lars Bochmann](https://www.profil.com/hs-fs/hubfs/Mitarbeiter/Lars_Bochmann.png?width=154&height=176&name=Lars_Bochmann.png) ### Our expert **Dr. Lars Bochmann** Chief Commercial Officer [![Contact](https://no-cache.hubspot.com/cta/default/481167/91d280fd-9078-4c41-a595-11e65c2e02d1.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/91d280fd-9078-4c41-a595-11e65c2e02d1) ![Pikto_Testimonials](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Pikto_Testimonials.png?width=81&height=90&name=Pikto_Testimonials.png) ### "Profil has excellent subject recruitment capabilities. The screening system makes it very efficient." **Dr. Chun Shen, CEO, Genova**   [![Subject Database_Nov2022](https://www.profil.com/hs-fs/hubfs/Pictures/Subject%20Database_Nov2022.png?width=1045&height=779&name=Subject%20Database_Nov2022.png) ![enlarge](https://www.profil.com/hubfs/BLUE_MOON/piktos/Lupe-01-1.svg) ](https://www.profil.com/hubfs/Pictures/Subject%20Database_Nov2022.png?hsLang=en-us) [![Treatment regiment of Type 2 diabetes subjects_Nov2022](https://www.profil.com/hs-fs/hubfs/Pictures/Treatment%20regiment%20of%20Type%202%20diabetes%20subjects_Nov2022.png?width=707&height=753&name=Treatment%20regiment%20of%20Type%202%20diabetes%20subjects_Nov2022.png) ![enlarge](https://www.profil.com/hubfs/BLUE_MOON/piktos/Lupe-01-1.svg) ](https://www.profil.com/hubfs/Pictures/Treatment%20regiment%20of%20Type%202%20diabetes%20subjects_Nov2022.png?hsLang=en-us) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_References.png?width=49&height=49&name=Icon_References.png) #### References We have published with the following sponsors: ![Referenzen](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Referenzen.gif "Referenzen") [View more](https://www.profil.com/knowledge-center/references?hsLang=en-us) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Certificates.png?width=44&height=49&name=Icon_Certificates.png) #### Certificates | ![13485_Zertifikatssiegel_black_A3](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_134852016_certificate_blue.png) ISO 13485:2016 ![27001_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_27001_certificate_.png) ISO 27001 | ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_9001-2015_certificate.png) ISO 9001:2015 ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/BVMA_Logo_Certificate_size.png) BVMA Member | | --- | --- | ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Publications.png?width=44&height=49&name=Icon_Publications.png) #### Publications Suico, J. G. et al. 2020. Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study. Diabetes Ther. 2020 Jul;11(7):1591-1603. [View all](https://www.profil.com/knowledge-center/publications?hsLang=en-us) Profil has an extensive diabetes patient database that is kept current by a team of dedicated recruitment coordinators. At our in-house clinic, we work to ensure patient compliance with physician’s instructions and clinical trial conditions, so our repeat participants understand the needs of pharmaceutical trials. We have more than 27,000 subjects ready to take part in clinical studies on diabetes and obesity. ###### Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · 41460 - Neuss, Germany Telefon +49-2131-4018-345 · marketing@profil.com [Imprint](https://www.profil.com/imprint?hsLang=en-us) | [Privacy Policy](https://www.profil.com/privacy?hsLang=en-us)